Workflow
icon
Search documents
阿科力:聚醚胺需求静待复苏,COC千吨装置建成待投放
Huaan Securities· 2024-09-04 04:30
Investment Rating - The investment rating for the company is "Accumulate" (maintained) [1] Core Views - The demand for polyether amines is awaiting recovery, and the COC thousand-ton facility is ready for deployment [1] - The company's revenue for the first half of 2024 was 2.42 billion yuan, a year-on-year decrease of 13.30%, with a net profit attributable to shareholders of 1.98 million yuan, down 87.75% year-on-year [1] - The company is facing pressure on prices and profitability due to capacity expansion in the polyether amine industry and lower-than-expected offshore wind power installations [1][2] - The company maintains a focus on high-end, quality clients and has established good relationships with well-known companies [1] - The COC material has achieved mass production and is expected to meet regulatory requirements for trial production [1] Financial Summary - The company expects net profits for 2024-2026 to be 0.22 billion yuan, 1.07 billion yuan, and 2.21 billion yuan, respectively, with corresponding P/E ratios of 147.40X, 29.73X, and 14.45X [2] - Revenue is projected to recover with a year-on-year growth of 9.7% in 2024, followed by 54.3% in 2025 and 36.5% in 2026 [4][7] - The gross margin is expected to stabilize around 14.5% in 2024, increasing to 30.5% by 2026 [4][7] - The company’s total assets are projected to grow from 933 million yuan in 2023 to 1.384 billion yuan in 2026 [6][7]
圣邦股份:Q2业绩延续好转态势,公司竞争力不断提升!"#$%
Huaan Securities· 2024-09-04 00:31
圣邦股份( [Table_StockNameRptType] 300661) 公司点评 Q2 业绩延续好转态势,公司竞争力不断提升 | --- | --- | --- | |-------------------------------------|------------|-------------| | | | | | [Table_Rank] 投资评级:买入(维持) | | | | 报告日期: | 2024-09-03 | | | [Table_BaseData] 收盘价(元) | | 70.20 | | 近 12 个月最高/最低(元) | | 98.29/58.42 | | 总股本(百万股) | | 472 | | 流通股本(百万股) | | 452 | | 流通股比例( % ) | | 95.88 | | 总市值(亿元) | | 331 | | 流通市值(亿元) | | 318 | [公司Table_Chart] 价格与沪深 300 走势比较 -36% -20% -5% 11% 27% 9/23 12/23 3/24 6/24 圣邦股份 沪深300 [Table_Author] 分析师:陈耀波 执业 ...
华菱钢铁:Q2业绩环增,静待需求进一步催化
Huaan Securities· 2024-09-03 23:42
[Table_Profit] 华菱钢铁( [Table_StockNameRptType] 000932) 公司点评 Q2 业绩环增,静待需求进一步催化 主要观点: ⚫[Table_Summary] 华菱钢铁发布 2024 年半年报 公司 24H1 实现营业收入 759.5 亿元,同比-4.53%;实现归母净利润 13.31 亿元,同比-48.16%。其中单 Q2 实现营业收入 389.02 亿元,同 比-1.92%,环比+5%;实现归母净利润 9.40 亿元,同比-50%,环比 +140%。 ⚫ 需求拖累钢价,行业整体承压 行业角度,今年上半年国内外经济面临一定挑战,钢铁行业经历深度调 整,CSPI 中国钢材价格指数同比-4.89%,成本方面据公司公告重点企 业国产铁精矿/进口粉矿采购成本同比分别+8.36%/+4.06%,24H1 黑色 金属冶炼和压延加工业累计实现利润总额-3.1 亿元。公司角度,24H1 公司板材收入 337.5 亿元(同比-12.8%)、长材收入 161.0 亿元(同比 -15.7%)、钢管收入 61.1 亿元(同比-6.9%)。24H1 钢材销量 1269 万 吨(同比-6%),其 ...
赤峰黄金:矿产金量价齐增,降本控费显成效
Huaan Securities· 2024-09-03 18:00
[Table_Profit] 赤峰黄金( [Table_StockNameRptType] 600988) 公司点评 矿产金量价齐增,降本控费显成效 主要观点: ⚫[Table_Summary] 赤峰黄金发布 2024 年半年报 公司 24H1 实现营业收入 41.96 亿元,同比+24.45%;实现归母净利润 7.11 亿元,同比+127.75%。其中单 Q2 实现营业收入 23.42 亿元,同 比+31.22%,环比+26.35%;实现归母净利润 5.10 亿元,同比+115.46%, 环比+154.35%。 ⚫ 黄金量价齐增,降息预期演绎下半年有望延续高景气 公司 24H1 黄金板块收入 37.58 亿元(同比+23.23%),其中黄金产量 达到 7.55 吨(同比+9.72%),价格方面 6 月末伦敦现货黄金定盘价较 年初上涨 12.34%,Q3 以来降息预期升温,8 月下旬较 6 月末上涨 7.74%,考虑到国际地缘政治冲突延续,黄金资产配置价值持续提升、 我们认为后续黄金价格仍有提升空间。公司吉隆矿业年新增 18 万吨金 矿石选矿扩建项目 7 月启动试生产,预期选矿处理能力增长 150%;老 挝万 ...
昊华科技:二季度环比改善,中化蓝天即将并表
Huaan Securities· 2024-09-03 17:36
| --- | --- | |---------------------------------------|-------------| | | | | [Table_Rank] 投资评级:买入(维持) | | | 报告日期: 2024-09-03 | | | [Table_BaseData] 收盘价(元) | 26 | | 近 12 个月最高 / 最低(元) | 34.61/24.45 | | 总股本(百万股) | 1109 | | 流通股本(百万股) | 904 | | 流通股比例( % ) | 81.53 | | 总市值(亿元) | 288 | | 流通市值(亿元) | 235 | [Table_Chart] 公司价格与沪深 300 走势比较 -30% -20% -10% 0% 10% 9/2 11/2 1/2 3/2 5/2 7/2 9/2 昊华科技 沪深300 [Table_Author] 分析师:王强峰 执业证书号:S0010522110002 电话:13621792701 邮箱:wangqf@hazq.com 分析师:潘宁馨 执业证书号:S0010524070002 电话:1381656246 ...
凯盛新材:主营产品景气磨底,PEKK材料逐步放量
Huaan Securities· 2024-09-03 17:30
Investment Rating - The investment rating for the company is "Buy" (maintained) [1][2] Core Views - The main viewpoint is that the company's main products are experiencing a downturn, leading to short-term pressure on performance, particularly in the chlorosulfonic acid and aramid sectors [1] - The company is expected to see growth in PEKK material production, which has significant strategic importance and high added value, with a focus on domestic production capabilities [1] - The company is actively expanding its product line and has made significant progress in new product development, which is expected to support future performance growth [1] Financial Performance Summary - In the first half of 2024, the company reported operating revenue of 495 million yuan, a year-on-year increase of 0.54%, and a net profit attributable to shareholders of 54 million yuan, a year-on-year decrease of 47.60% [1] - The second quarter of 2024 saw operating revenue of 255 million yuan, a year-on-year increase of 4.41%, while net profit attributable to shareholders was 28 million yuan, a year-on-year decrease of 45.97% [1] - The company's gross margin in the inorganic compounds segment was 20.29%, a year-on-year decrease of 16.36 percentage points, and in the carboxylic compounds segment, it was 28.35%, a year-on-year decrease of 12.07 percentage points [1] Future Earnings Forecast - The forecasted net profit attributable to shareholders for 2024, 2025, and 2026 is expected to be 148 million yuan, 205 million yuan, and 262 million yuan respectively, with corresponding year-on-year growth rates of -6.1%, 38.0%, and 28.0% [2] - The projected operating revenue for the same years is 1.212 billion yuan, 1.660 billion yuan, and 2.049 billion yuan, with year-on-year growth rates of 22.8%, 37.0%, and 23.4% respectively [2]
卫光生物:二季度营收端增速亮眼,核心单品收入稳健增长
Huaan Securities· 2024-09-03 09:40
卫光生物( [Table_StockNameRptType] 002880) 公司点评 | --- | --- | --- | |-----------------------------------------------------------------------------------------------------------------------|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...
中国西电:业绩符合预期,海内外需求共振
Huaan Securities· 2024-09-03 09:39
| --- | --- | --- | --- | --- | |-------|---------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 司深 度 | | | | | | | | | | | | | | | | | | | | | | [Table_StockNameRptType] 中国西电( 601179) 业绩符合预期,海内外需求共振 主要观点: 公司点评 正 泰电器 (6018 77) 公司 研究/公司 点评 ⚫[Table_Summary] 业绩 公司公布 2024H1 业绩,实现营收 102.84 亿元,YoY+8.24%;实现归母 净利润 4.52 亿元,YoY+5.23%;实现扣非归母净利润 4.71 亿元, YoY+22.87%。其中 2024Q2 实现营收 56.02 亿元,YoY+19.03%;实现归 母净 ...
福田汽车:商用车周期复苏,新技术新产品加速落地
Huaan Securities· 2024-09-03 07:42
福田汽车( [Table_StockNameRptType] 600166) 公司覆盖 商用车周期复苏,新技术新产品加速落地 | --- | --- | |----------------------------------------|-----------| | [Table_Rank] 投资评级:买入 首次覆盖 | | | 报告日期: 2024-09-03 | | | [Table_BaseData] 收盘价(元) | 2.29 | | 近 12 个月最高 / 最低(元) | 3.73/2.20 | | 总股本(百万股) | 8,004 | | 流通股本(百万股) | 6,575 | | 流通股比例( % ) | 82.15 | | 总市值(亿元) | 183 | | 流通市值(亿元) | 151 | [公司价格与沪深 Table_Chart] 300 走势比较 -46% -31% -16% 0% 15% 9/23 12/23 3/24 6/24 福田汽车 沪深300 [Table_Author] 分析师:姜肖伟 执业证书号:S0010523060002 电话:18681505180 邮箱:jiangx ...
拓普集团:新产品与新客户放量,收入持续高增长
Huaan Securities· 2024-09-03 07:42
[Table_Profit] 拓普集团( [Table_StockNameRptType] 601689) 公司点评 新产品与新客户放量,收入持续高增长 | --- | --- | --- | |-------------------------------------|------------|-------------| | | | | | [Table_Rank] 投资评级:买入(维持) | | | | 报告日期: | 2024-09-03 | | | [Table_BaseData] 收盘价(元) | | 31.83 | | 近 12 个月最高 / | 最低(元) | 50.40/29.57 | | 总股本(百万股) | | 1,686 | | 流通股本(百万股) | | 1,686 | | 流通股比例( % ) | | 100.00 | | 总市值(亿元) | | 537 | | 流通市值(亿元) | | 537 | -51% -36% -21% -5% 10% 9/23 12/23 3/24 6/24 拓普集团 沪深300 [Table_Author] 分析师:张志邦 执业证书号:S0010523 ...